HOFFMAN STEPHEN J
Insider CIK 1190418 · ALTH Director · TTPH 10% owner · DRNA Director, 10% owner · ARPO Chief Executive Officer, Director · ACRX Director, 10% owner · GNCA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TLPH TALPHERA, INC. | A Award deriv | 2026-06-22 | 2026-06-24 | 30,700 | — | $0 | 30,700 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2026-06-22 | 2026-06-24 | 5,100 | — | $0 | 13,959 | SEC↗ |
| TLPH TALPHERA, INC. | A Award deriv | 2025-10-23 | 2025-10-24 | 25,600 | — | $0 | 25,600 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2025-10-23 | 2025-10-24 | 4,267 | — | $0 | 8,859 | SEC↗ |
| TLPH TALPHERA, INC. | A Award deriv | 2024-06-24 | 2024-06-24 | 13,044 | — | $0 | 13,044 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2024-06-24 | 2024-06-24 | 2,174 | — | $0 | 4,592 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2023-10-10 | 2023-12-13 | 3,487 | — | $0 | 3,487 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2023-10-10 | 2023-12-13 | 581 | — | $0 | 2,418 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2022-07-15 | 2022-07-15 | 31,000 | — | $0 | 31,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2022-07-15 | 2022-07-15 | 15,500 | — | $0 | 36,750 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 3,333 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | U Tender | 2021-12-28 | 2021-12-29 | 16,157 | $38.25 | $618.0K | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2021-06-17 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2021-06-17 | 2021-06-17 | 10,000 | — | $0 | 21,250 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2021-06-03 | 2021-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 29,071 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2020-06-16 | 2020-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2020-06-16 | 2020-06-16 | 7,500 | — | $0 | 11,250 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2020-06-15 | 2020-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2020-06-15 | 2020-06-16 | 3,333 | — | $0 | 3,333 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2019-06-25 | 2019-06-25 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2019-06-25 | 2019-06-25 | 3,750 | — | $0 | 3,750 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2019-06-20 | 2019-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2019-05-14 | 2019-05-16 | 709,050 | — | $0 | 709,050 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2019-02-15 | 2019-02-20 | 365,000 | — | $0 | 365,000 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-11-12 | 2018-11-14 | 30,000 | $2.01 | $60.3K | 31,967 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | P Buy | 2018-11-09 | 2018-11-14 | 1,967 | $1.95 | $3.8K | 1,967 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2018-06-21 | 2018-06-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2018-04-23 | 2018-04-25 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2017-12-14 | 2017-12-18 | 586,012 | $5.50 | $3.22M | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2017-07-18 | 2017-07-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2016-06-14 | 2016-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2016-06-07 | 2016-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2015-06-25 | 2015-06-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2015-03-17 | 2015-03-17 | 700,000 | $8.25 | $5.78M | 1,992,415 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | A Award deriv | 2015-02-26 | 2015-03-02 | 5,042 | — | $0 | 5,042 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2014-06-18 | 2014-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2014-04-16 | 2014-04-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2014-03-12 | 2014-03-14 | 4,493 | — | $0 | 4,493 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | J Other | 2014-03-12 | 2014-03-14 | 300,000 | — | $0 | 1,890,146 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | J Other | 2014-03-07 | 2014-03-11 | 1,300,000 | — | $0 | 2,871,933 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | C Conversion deriv | 2014-02-10 | 2014-02-11 | 9,253,255 | — | $0 | 0 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | C Conversion deriv | 2014-02-10 | 2014-02-11 | 3,140,414 | — | $0 | 0 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2014-02-10 | 2014-02-11 | 250,931 | $12.00 | $3.01M | 1,292,415 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | C Conversion | 2014-02-10 | 2014-02-11 | 263,900 | — | $0 | 1,041,484 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | C Conversion | 2014-02-10 | 2014-02-11 | 777,584 | — | $0 | 777,584 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 1,043,429 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 312,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 755 | — | $0 | 755 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 179,322 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 21,697 | — | $0 | 21,697 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-05 | 21,697 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2014-02-04 | 2014-02-05 | 200,000 | $15.00 | $3.00M | 1,734,751 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-05 | 312,000 | — | $0 | 312,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-05 | 179,322 | — | $0 | 491,322 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-05 | 1,043,429 | — | $0 | 1,534,751 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2013-09-12 | 2013-09-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | U Tender | 2012-09-04 | 2012-09-05 | 472,871 | $1.82 | $860.6K | 0 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | U Tender | 2012-09-04 | 2012-09-05 | 92,000 | $1.82 | $167.4K | 0 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | U Tender | 2012-09-04 | 2012-09-05 | 200 | $1.82 | $364 | 0 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | U Tender | 2012-09-04 | 2012-09-05 | 200 | $1.82 | $364 | 0 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | U Tender | 2012-09-04 | 2012-09-05 | 200 | $1.82 | $364 | 0 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | U Tender | 2012-09-04 | 2012-09-05 | 200 | $1.82 | $364 | 0 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2012-07-24 | 2012-07-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy deriv | 2012-05-29 | 2012-05-31 | 256,228 | $0.13 | $33.3K | 256,228 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2012-05-29 | 2012-05-31 | 284,698 | $3.40 | $968.0K | 4,161,933 | SEC↗ |
| ALTH ALLOS THERAPEUTICS INC | A Award | 2011-12-13 | 2012-04-13 | 90,000 | — | $0 | 92,000 | SEC↗ |